Please login to the form below

Not currently logged in
Email:
Password:

Quintiles signs local bioanalytical deal for South Korea

Partners with Seoul-based contract research organisation BioCore

Quintiles has signed a partnership agreement that will allow it to complement its global bioanalytical service with a local offering for South Korea and other Asian markets.

The two-year deal with BioCore will see the Seoul-based contract research organisation (CRO) provide its services to Quintiles exclusively for a two-year period.

Jenny Zhang, vice president and general manager of Asia Laboratories at Quintiles, said: “Gathering high-quality bioanalytical data early in development is crucial to biopharma companies making informed decisions that increase their probability of success in expensive later-stage trials.

“This partnership with BioCore is part of our plan to add local capabilities as needed to augment Quintiles' GLP (Good Laboratory Practice) bioanalytics lab and CAP (College of American Pathologists)-accredited network of central labs.”

Quintiles has been operating in South Korea since 2000 but the firm's global bioanalytical capability only began picking up speed with its 2011 acquisition of Advion BioServices.

Advion, which is now called Advion Bioanalytical Labs and operates as a Quintiles company, will continue to serve global customers but Quintiles will now offer BioCore as a local bioanalytical lab for Asia.

BioCore is South Korea's largest provider of bioanalytical liquid chromatography-tandem mass spectrometry services and in 2005 it became South Korea's first GLP-complaint centralised bioanalytical CRO.

Hyung Sik Choie, BioCore president and CEO, said: “This partnership expands BioCore's bioanalysis and bioequivalence studies beyond Korea to other Asian countries. Our vision is to become more global; this alliance advances our efforts to achieve that vision.” 

South Korea's pharmaceutical market has seen consistent double-digit growth over the last five years and consultants IMS Health consider it to be the fastest-growing developed country.

As a result of this, and the high level of industry interest in the region, the region has seen a number of CRO deals in South Korea and its neighbours from the likes of INC Research, Parexel and PRA.

10th January 2013

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Tonic Life Communications

We are the go-to agency for both established brands and ambitious startups. Here’s why: Deep experience. In the life sciences...

Latest intelligence

The vitamin D deficiency: should we act?
Healthcare PR agency Say Communications analyses whether headlines are able to trigger a behavioural change with regards to the vitamin D deficiency issue....
Is obesity the new smoking?
Is obesity the new smoking? The healthcare PR team at Say communications analyses the question posed by NHS Chief executive Simon Stevens....
Children, the weight issue and how we deal with this responsibly?
Say Communication, Healthcare PR Agency, looks at how children deal with the weight issue and how we can approach it responsibly....

Infographics